Etao International Co., Ltd.

OTC: ETAOF · Healthcare · Medical - Care Facilities

PublicHQ New York, NY · New YorkCIK 0001939696Reports USD

#413 of 1,422 Healthcare companies by revenue55th-percentile growth

EA Score

——

FH —DQ 1GM —SS 34

v0.1 · 25/100 weight · pillars only

↑ workforce scale, Piotroski F · ↓ disclosure history, filing timeliness

Methodology →

Revenue TTM

$58.1M

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$896.7M

Employees

3,600

as of 2026-07-12

Market cap

$512

as of 2026-07-12

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$58.1M$58.1M2022

Net income-$896.7M-$896.7M2022

Operating income-$737.1M-$737.1M2022

Total assets$53.0M$53.0M2022

Liabilities$59.0M$59.0M2022

Equity-$15.6M-$15.6M2022

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Etao International Co., Ltd.’s revenue?

Etao International Co., Ltd. booked $58.1M in FY2022 revenue, growing 8.9% year over year — about the middle of the pack among Healthcare companies we track, at a -1544.4% net margin.

Peers · Healthcare

Journey Medical Corporation52D Fortress Biotech, Inc.62C Kestra Medical Technologies, Ltd.——Flower One Holdings Inc.——Champions Oncology, Inc.——CVRx, Inc.50D

Neighbors

New York →

JPMorgan Chase & Co.$182.4B72B Morgan Stanley$34.3B61C The Goldman Sachs Group, Inc.——Philip Morris International Inc.$40.6B86A American Express Company$41.3B78B+Citigroup Inc.$85.2B55C

Key facts

CEOWen Sheng Liu

SectorHealthcare

IndustryMedical - Care Facilities

HeadquartersNew York, NY

ExchangeOTC: ETAOF

Employees3,600

IPO date2023-02-21

Latest filings

6-K2024-05-06 6-K2024-05-01 6-K2024-03-13 6-K2024-03-08 6-K2024-02-08 6-K2024-01-31 6-K2023-12-21 6-K2023-12-18

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.